LLY
LLY
Eli Lilly and Company
$1,005.96
-$9.79 (-0.96%)
Mkt Cap: $947.35B
Home / LLY / Financial Statements

Eli Lilly and Company (LLY) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$72.25B
$65.18B ↑44.7%
$45.04B ↑32.0%
$34.12B ↑19.6%
$28.54B ↑0.8%
$28.32B
Cost of Revenue
$11.92B
$10.56B ↑25.5%
$8.42B ↑18.9%
$7.08B ↑6.8%
$6.63B ↓9.3%
$7.31B
Gross Profit
$60.33B
$54.62B ↑49.1%
$36.62B ↑35.4%
$27.04B ↑23.4%
$21.91B ↑4.3%
$21.01B
R&D Expenses
$14.11B
$13.34B ↑21.4%
$10.99B ↑18.0%
$9.31B ↑29.5%
$7.19B ↑3.8%
$6.93B
SG&A Expenses
$11.67B
$11.09B ↑36.4%
$8.13B ↑17.2%
$6.94B ↑14.4%
$6.07B ↓1.2%
$6.14B
Operating Income
$33.14B
$29.70B ↑69.7%
$17.50B ↑62.2%
$10.79B ↑24.7%
$8.65B ↑9.1%
$7.93B
Interest Expense
$883.60M
$795.30M ↑1.9%
$780.60M ↑60.7%
$485.90M ↑46.5%
$331.60M ↓2.4%
$339.80M
Income Tax
$5.85B
$5.09B ↑143.6%
$2.09B ↑59.1%
$1.31B ↑134.0%
$561.60M ↓2.1%
$573.80M
Net Income
$25.27B
$20.64B ↑94.9%
$10.59B ↑102.1%
$5.24B ↓16.1%
$6.24B ↑11.9%
$5.58B
EBITDA
$33.13B
$27.94B ↑83.5%
$15.23B ↑77.7%
$8.57B ↓1.1%
$8.66B ↑7.7%
$8.04B
EPS
28.15
22.95 ↑96.0%
11.71 ↑101.9%
5.80 ↓11.7%
6.57 ↑12.3%
5.85
Shares Out (Diluted)
3.59B
898.00M ↓0.7%
904.06M ↑0.1%
903.28M ↓4.9%
950.18M ↓0.4%
953.65M